文献速递胃肠外科肝胆胰外科急腹症与外科感染

腔内负压治疗用于上消化道漏:安全、有效且微创的回顾性观察研究

Endoluminal vacuum therapy for upper gastrointestinal leaks: safe, effective and minimally invasive - insights from a retrospective observational study.
PubMed 文献 · Surg Endosc · 2025-11-13

该单中心回顾性观察研究纳入2019至2024年30例上消化道漏患者,采用腔内负压治疗(EVT),主要终点为漏口愈合。结果显示27/30(90.0%)实现漏口闭合,55%联合内镜巩固治疗,中位海绵更换5次,中位愈合时间30天,并发症5/30(16.6%)均为轻微,无漏相关死亡。

要点

  • EVT对上消化道漏的漏口闭合率达90.0%(27/30)。
  • 中位海绵更换5次,中位愈合时间30天,并发症均为轻微。
  • 联合内镜巩固治疗可能改善结局,但需进一步前瞻性研究验证。

核心结论

  • EVT是处理上消化道漏的有效且安全治疗选择,成功率高、发病率低。
  • 联合内镜巩固治疗可能增强疗效,但需前瞻性多中心研究以标准化EVT适应证、实施和患者选择标准。

研究设计与样本

  • 分析患者人口学、漏病因、EVT技术细节、并发症和结局,并进行总体及按漏病因的亚组分析。
  • 主要终点为漏口愈合,次要终点包括发病率、死亡率、海绵更换次数、治疗时长和额外干预需求。

主要发现

  • 30例患者中,食管切除相关漏19例(63.3%),食管医源性穿孔1例(3.3%),胃切除相关漏3例(10.0%),袖状胃切除相关漏7例(23.3%)。
  • EVT实现漏口闭合27/30例(90.0%),55%联合内镜巩固治疗,中位海绵更换5次(3.0-6.0),中位愈合时间30天(18.0-41.0)。
  • EVT以腔内方式应用占66.7%,自漏诊断起中位应用时间1天(0.0-6.0),并发症5/30例(16.6%),均为轻微。
  • 亚组分析显示胃切除和食管切除后漏的成功率更高、恢复更快。
  • 中位住院时间46天(35.0-71.0),无漏相关死亡。

临床怎么用

  • 对于上消化道漏,EVT可作为微创治疗选择,尤其适用于胃切除和食管切除后漏。
  • 可考虑联合内镜巩固治疗以提高疗效。
  • 需注意EVT治疗周期较长,中位愈合时间30天,中位住院时间46天。

局限性

  • 单中心回顾性观察研究,样本量有限(30例),结论外推需谨慎。
  • EVT仍为非标准化技术,需进一步前瞻性多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Upper gastrointestinal (UGI) leaks are serious complications with high morbidity and mortality. Endoluminal vacuum therapy (EVT) has emerged as a minimally invasive alternative to surgical management, offering promising outcomes. However, EVT remains a non-standardized technique and data regarding its effectiveness remain heterogeneous. METHODS: we conducted an observational, retrospective, single-center study from the cohort of patients with UGI leaks treated with EVT at Hospital General Universitario Gregorio Marañón between January 2019 and December 2024. Patient demographics, leak etiology, EVT technical details, complications, and outcomes were analyzed. Overall analysis of the sample and subgroups analysis regarding the leak etiology were conducted. The primary endpoint was leak resolution. Secondary endpoints included morbidity and mortality, number of sponge exchanges, duration of therapy and need for additional interventions. RESULTS: 30 patients were included; 19 (63.3%) esophaguectomy-associated leaks, 1 (3.3%) esophagueal iatrogenic perforation, 3 (10.0%) gastrectomy-associated leaks and 7 (23.3%) sleeve gastrectomy-associated leaks. EVT achieved leak closure in 27/30 patients (90.0%), combined with endoscopic consolidation therapy in 55%, with a median of 5 (3.0-6.0) sponge exchanges and a median healing time of 30 (18.0-41.0) days. EVT was applied intracavitary in 66.7% in a median time of 1 (0.0-6.0) day since the leak diagnosis and complications occurred in 5/30 (16.6%), all minor. Subgroup analysis revealed a higher success rates and faster recovery in leaks after gastrectomy and esophagectomy. Median hospital stay was 46 (35.0-71.0) days and there was no mortality related to the leak. CONCLUSIONS: our sample analysis revealed EVT as an effective and safe therapeutic option for managing UGI leaks, with high success rates and low morbidity. Nevertheless, its combined use with endoscopic consolidation therapy may enhance outcomes. Given the limitations of our study, further prospective, multicenter studies are needed to extrapolate our findings and contribute to standardize EVT indications, implementation, and patient selection criteria.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Sánchez-Rodríguez M, Monge-Brandi L, García-Lledó J, et al. Endoluminal vacuum therapy for upper gastrointestinal leaks: safe, effective and minimally invasive - insights from a retrospective observational study. Surg Endosc. 2025. PMID: 41233644. doi:10.1007/s00464-025-12381-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。